Study of VDIs Ultra-High Frequency Electrocardiogram to Diagnose Ventricular Electrical Dyssynchrony in Adults with Bradycardia or Heart Failure
Comparing UHF-ECG with Standard 12-Lead ECG in Patients Needing a Pacemaker
Led by VDI Technologies · Updated on 2026-05-05
360
Participants Needed
12
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of the VDI UHF-ECG System for diagnosing ventricular dyssynchrony in patients with bradycardia and heart failure who are scheduled for pacemaker implantation. This observational study compares the new Ultra High Frequency Electrocardiogram UHF-ECG device with the standard 12-lead ECG to see how well it predicts electrical dyssynchrony in the heart.
Participants will undergo both the standard ECG and the UHF-ECG measurements sequentially before their pacemaker procedure. The study focuses on adults with specific heart conditions such as bradycardia with different conduction patterns or heart failure with left bundle branch block. The investigational device is used to gather detailed electrical activity data to improve diagnosis.
During the study, researchers will collect and compare ECG data from both devices before the pacemaker implant. Participants will be monitored for predictive agreement between the UHF-ECG and standard ECG results. The study involves informed consent, adherence to study procedures, and a pregnancy test for women of childbearing potential. The trial is expected to continue until May 2027.
CONDITIONS
Brief Title
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
Research Team
R
Randy LaBounty
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Adults with bradycardia or heart failure scheduled for first time pacemaker implant (including CRT/CSP) with specific conduction patterns or heart failure with LBBB
Understands the nature of the study and agrees to comply with study requirements
Provides written informed consent
Negative pregnancy test prior to procedure for participants of child-bearing potential
You will not qualify if you...
Complete AV block without stable escape rhythm or no measurable QRS
Previous or current pacemaker or defibrillator implant
Conditions making 12-lead ECG difficult, such as allergy to ECG pads, burns, or open wounds
Currently enrolled in another investigational device or drug trial in active treatment phase
Other co-morbid conditions limiting participation or study integrity
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Implementation
Duration - Day of pacemaker implantation
Participants scheduled for pacemaker implantation undergo standard ECG and VDI UHF-ECG measurements sequentially before their procedure.
1 visit (in-person)
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
A Study Comparing Standard Right Ventricular Pacing with New Physiological Pacing Methods for Treating Slow Heart Rates
Phase 2 Study of 18F-mFBG PET Imaging
for Heart Failure Patients with Ischemic Cardiomyopathy
and Implantable Cardioverter-Defibrillators
Post-Discharge Counseling and Phone Follow-Up to Reduce Heart Failure Readmissions at Komfo Anokye Teaching Hospital
Myocardial Energetic Profiling Using 31P Magnetic Resonance Spectroscopy
and Prognostic Assessment Across Heart Failure and Cardiomyopathy Types
3D Imaging Study of Right Heart Function During Mechanical Pump Placement for Heart Failure
Evaluating Cardiac Fibrosis in Heart Failure Using 68Ga-FAPI PETCT Compared to MRI
A Pilot Study in Patients with HFrEF and HFpEF
Study of Vascular Function and Exercise Effects in Aging and Cardiovascular Diseases Including COPD and Pulmonary Hypertension
A Phase I Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Effects of Oral Doses of HRS-5765 in Healthy Adults Aged 18 to 65
Phase I Study Evaluating Safety and Pharmacokinetics of Single and Multiple Oral Doses of HRS-7156 in Healthy Adults
Optimizing Heart Failure and Chronic Kidney Disease Treatment in Elderly Patients Using Sodium Zirconium Cyclosilicate to Manage Potassium Levels
Ventricular Electrical Delay Measured From Body Surface ECGs Is Associated With Cardiac Resynchronization Therapy Response in Left Bundle Branch Block Patients From the MADIT-CRT Trial (Multicenter Automatic Defibrillator Implantation-Cardiac Resynchronization Therapy).